type here...

CATEGORIES

Pharmaceutics

LATEST

1234...11Page 3 of 11

TRENDING

EDITORS CHOICE

Lilly commits Insulin Value Program, With $35 Copay Card

Medika Life -
Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.

BIO – Biotech Without Borders 

Gil Bashe, Medika Life Editor -
This year’s gathering in Boston—a city long synonymous with health innovation—welcomed more than 20,000 attendees from across the globe. But what stood out most...

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Killing The Coronavirus. A New Treatment Shows 99.9 Percent Efficacy

Medika Life -
Enovid is a groundbreaking treatment that claims it prevents the coronavirus from invading your body. This nasal spray kills the virus in the nasal passage

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories